Patent · US Active

Highly purified antiendotoxin compound

US8377893B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 16, 2010
Grant dateFeb 19, 2013
Priority date
Expiry dateJun 16, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions containing a highly purified antiendotoxin compound and methods of preparing and using such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.